These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
320 related articles for article (PubMed ID: 23603111)
1. Estrogen receptor β ligand therapy activates PI3K/Akt/mTOR signaling in oligodendrocytes and promotes remyelination in a mouse model of multiple sclerosis. Kumar S; Patel R; Moore S; Crawford DK; Suwanna N; Mangiardi M; Tiwari-Woodruff SK Neurobiol Dis; 2013 Aug; 56():131-44. PubMed ID: 23603111 [TBL] [Abstract][Full Text] [Related]
2. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects. Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441 [TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor (ER) β expression in oligodendrocytes is required for attenuation of clinical disease by an ERβ ligand. Khalaj AJ; Yoon J; Nakai J; Winchester Z; Moore SM; Yoo T; Martinez-Torres L; Kumar S; Itoh N; Tiwari-Woodruff SK Proc Natl Acad Sci U S A; 2013 Nov; 110(47):19125-30. PubMed ID: 24191028 [TBL] [Abstract][Full Text] [Related]
4. Matrine promotes oligodendrocyte development in CNS autoimmunity through the PI3K/Akt signaling pathway. Liu SQ; Zhang ML; Zhang HJ; Liu FZ; Chu RJ; Zhang GX; Zhu L Life Sci; 2017 Jul; 180():36-41. PubMed ID: 28499934 [TBL] [Abstract][Full Text] [Related]
5. Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination. Crawford DK; Mangiardi M; Song B; Patel R; Du S; Sofroniew MV; Voskuhl RR; Tiwari-Woodruff SK Brain; 2010 Oct; 133(10):2999-3016. PubMed ID: 20858739 [TBL] [Abstract][Full Text] [Related]
6. Multiple functional therapeutic effects of the estrogen receptor β agonist indazole-Cl in a mouse model of multiple sclerosis. Moore SM; Khalaj AJ; Kumar S; Winchester Z; Yoon J; Yoo T; Martinez-Torres L; Yasui N; Katzenellenbogen JA; Tiwari-Woodruff SK Proc Natl Acad Sci U S A; 2014 Dec; 111(50):18061-6. PubMed ID: 25453074 [TBL] [Abstract][Full Text] [Related]
7. Increase in chemokine CXCL1 by ERβ ligand treatment is a key mediator in promoting axon myelination. Karim H; Kim SH; Lapato AS; Yasui N; Katzenellenbogen JA; Tiwari-Woodruff SK Proc Natl Acad Sci U S A; 2018 Jun; 115(24):6291-6296. PubMed ID: 29844175 [TBL] [Abstract][Full Text] [Related]
8. FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models. Rajendran R; Böttiger G; Stadelmann C; Karnati S; Berghoff M Cells; 2021 Apr; 10(4):. PubMed ID: 33924474 [TBL] [Abstract][Full Text] [Related]
9. Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis. Giacoppo S; Pollastro F; Grassi G; Bramanti P; Mazzon E Fitoterapia; 2017 Jan; 116():77-84. PubMed ID: 27890794 [TBL] [Abstract][Full Text] [Related]
10. Fingolimod treatment promotes proliferation and differentiation of oligodendrocyte progenitor cells in mice with experimental autoimmune encephalomyelitis. Zhang J; Zhang ZG; Li Y; Ding X; Shang X; Lu M; Elias SB; Chopp M Neurobiol Dis; 2015 Apr; 76():57-66. PubMed ID: 25680941 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis. Kerstetter AE; Padovani-Claudio DA; Bai L; Miller RH Exp Neurol; 2009 Nov; 220(1):44-56. PubMed ID: 19616545 [TBL] [Abstract][Full Text] [Related]
12. Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. Najm FJ; Madhavan M; Zaremba A; Shick E; Karl RT; Factor DC; Miller TE; Nevin ZS; Kantor C; Sargent A; Quick KL; Schlatzer DM; Tang H; Papoian R; Brimacombe KR; Shen M; Boxer MB; Jadhav A; Robinson AP; Podojil JR; Miller SD; Miller RH; Tesar PJ Nature; 2015 Jun; 522(7555):216-20. PubMed ID: 25896324 [TBL] [Abstract][Full Text] [Related]
13. Bu Shen Yi Sui capsule promotes remyelination correlating with Sema3A/NRP-1, LIF/LIFR and Nkx6.2 in mice with experimental autoimmune encephalomyelitis. Zhao PY; Wang YQ; Liu XH; Zhu YJ; Zhao H; Zhang QX; Qi F; Li JL; Zhang N; Fan YP; Li KN; Zhao YY; Lei JF; Wang L J Ethnopharmacol; 2018 May; 217():36-48. PubMed ID: 29428242 [TBL] [Abstract][Full Text] [Related]
14. G protein-coupled receptor 30 contributes to improved remyelination after cuprizone-induced demyelination. Hirahara Y; Matsuda KI; Yamada H; Saitou A; Morisaki S; Takanami K; Boggs JM; Kawata M Glia; 2013 Mar; 61(3):420-31. PubMed ID: 23281138 [TBL] [Abstract][Full Text] [Related]
15. A dual effect of ursolic acid to the treatment of multiple sclerosis through both immunomodulation and direct remyelination. Zhang Y; Li X; Ciric B; Curtis MT; Chen WJ; Rostami A; Zhang GX Proc Natl Acad Sci U S A; 2020 Apr; 117(16):9082-9093. PubMed ID: 32253301 [TBL] [Abstract][Full Text] [Related]
16. Neuregulin in neuron/glial interactions in the central nervous system. GGF2 diminishes autoimmune demyelination, promotes oligodendrocyte progenitor expansion, and enhances remyelination. Marchionni MA; Cannella B; Hoban C; Gao YL; Garcia-Arenas R; Lawson D; Happel E; Noel F; Tofilon P; Gwynne D; Raine CS Adv Exp Med Biol; 1999; 468():283-95. PubMed ID: 10635037 [TBL] [Abstract][Full Text] [Related]
18. Vortioxetine ameliorates experimental autoimmune encephalomyelitis model of multiple sclerosis in mice via activation of PI3K/Akt/CREB/BDNF cascade and modulation of serotonergic pathway signaling. Shafiek MS; Mekky RY; Nassar NN; El-Yamany MF; Rabie MA Eur J Pharmacol; 2024 Nov; 982():176929. PubMed ID: 39181226 [TBL] [Abstract][Full Text] [Related]
19. Estrogen mediates neuroprotection and anti-inflammatory effects during EAE through ERα signaling on astrocytes but not through ERβ signaling on astrocytes or neurons. Spence RD; Wisdom AJ; Cao Y; Hill HM; Mongerson CR; Stapornkul B; Itoh N; Sofroniew MV; Voskuhl RR J Neurosci; 2013 Jun; 33(26):10924-33. PubMed ID: 23804112 [TBL] [Abstract][Full Text] [Related]
20. Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination. Narayanan SP; Flores AI; Wang F; Macklin WB J Neurosci; 2009 May; 29(21):6860-70. PubMed ID: 19474313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]